These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 19830703)

  • 1. Impediment of NEMO oligomerization inhibits osteoclastogenesis and osteolysis.
    Darwech I; Otero J; Alhawagri M; Dai S; Abu-Amer Y
    J Cell Biochem; 2009 Dec; 108(6):1337-45. PubMed ID: 19830703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory osteolysis is regulated by site-specific ISGylation of the scaffold protein NEMO.
    Adapala NS; Swarnkar G; Arra M; Shen J; Mbalaviele G; Ke K; Abu-Amer Y
    Elife; 2020 Mar; 9():. PubMed ID: 32202502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The IkappaB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks osteoclastogenesis and bone erosion in inflammatory arthritis.
    Dai S; Hirayama T; Abbas S; Abu-Amer Y
    J Biol Chem; 2004 Sep; 279(36):37219-22. PubMed ID: 15252035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ubiquitin-like domain of IKKβ regulates osteoclastogenesis and osteolysis.
    Zhang Y; Otero JE; Abu-Amer Y
    Calcif Tissue Int; 2013 Jul; 93(1):78-85. PubMed ID: 23686246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysine392, a K63-linked ubiquitination site in NEMO, mediates inflammatory osteoclastogenesis and osteolysis.
    Alhawagri M; Yamanaka Y; Ballard D; Oltz E; Abu-Amer Y
    J Orthop Res; 2012 Apr; 30(4):554-60. PubMed ID: 21913221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IKKbeta activation is sufficient for RANK-independent osteoclast differentiation and osteolysis.
    Otero JE; Dai S; Alhawagri MA; Darwech I; Abu-Amer Y
    J Bone Miner Res; 2010 Jun; 25(6):1282-94. PubMed ID: 20200955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of IKK activation, through sequestering NEMO, blocks PMMA-induced osteoclastogenesis and calvarial inflammatory osteolysis.
    Clohisy JC; Yamanaka Y; Faccio R; Abu-Amer Y
    J Orthop Res; 2006 Jul; 24(7):1358-65. PubMed ID: 16705717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NEMO-binding domains of both IKKalpha and IKKbeta regulate IkappaB kinase complex assembly and classical NF-kappaB activation.
    Solt LA; Madge LA; May MJ
    J Biol Chem; 2009 Oct; 284(40):27596-608. PubMed ID: 19666475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-1-induced NF-kappaB activation is NEMO-dependent but does not require IKKbeta.
    Solt LA; Madge LA; Orange JS; May MJ
    J Biol Chem; 2007 Mar; 282(12):8724-33. PubMed ID: 17244613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The trimerization domain of NEMO is composed of the interacting C-terminal CC2 and LZ coiled-coil subdomains.
    Agou F; Traincard F; Vinolo E; Courtois G; Yamaoka S; Israël A; Véron M
    J Biol Chem; 2004 Jul; 279(27):27861-9. PubMed ID: 15107419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyubiquitination events mediate polymethylmethacrylate (PMMA) particle activation of NF-kappaB pathway.
    Yamanaka Y; Karuppaiah K; Abu-Amer Y
    J Biol Chem; 2011 Jul; 286(27):23735-41. PubMed ID: 21566132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymoquinone prevents RANKL-induced osteoclastogenesis activation and osteolysis in an in vivo model of inflammation by suppressing NF-KB and MAPK Signalling.
    Thummuri D; Jeengar MK; Shrivastava S; Nemani H; Ramavat RN; Chaudhari P; Naidu VG
    Pharmacol Res; 2015 Sep; 99():63-73. PubMed ID: 26022736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carnosic acid attenuates RANKL-induced oxidative stress and osteoclastogenesis via induction of Nrf2 and suppression of NF-κB and MAPK signalling.
    Thummuri D; Naidu VGM; Chaudhari P
    J Mol Med (Berl); 2017 Oct; 95(10):1065-1076. PubMed ID: 28674855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NEMO oligomerization and its ubiquitin-binding properties.
    Ivins FJ; Montgomery MG; Smith SJ; Morris-Davies AC; Taylor IA; Rittinger K
    Biochem J; 2009 Jun; 421(2):243-51. PubMed ID: 19422324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of NF-kappa B activation by peptides targeting NF-kappa B essential modulator (nemo) oligomerization.
    Agou F; Courtois G; Chiaravalli J; Baleux F; Coïc YM; Traincard F; Israël A; Véron M
    J Biol Chem; 2004 Dec; 279(52):54248-57. PubMed ID: 15466857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin (diferuloylmethane) inhibits receptor activator of NF-kappa B ligand-induced NF-kappa B activation in osteoclast precursors and suppresses osteoclastogenesis.
    Bharti AC; Takada Y; Aggarwal BB
    J Immunol; 2004 May; 172(10):5940-7. PubMed ID: 15128775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABIN-1 binds to NEMO/IKKgamma and co-operates with A20 in inhibiting NF-kappaB.
    Mauro C; Pacifico F; Lavorgna A; Mellone S; Iannetti A; Acquaviva R; Formisano S; Vito P; Leonardi A
    J Biol Chem; 2006 Jul; 281(27):18482-8. PubMed ID: 16684768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Embelin suppresses osteoclastogenesis induced by receptor activator of NF-κB ligand and tumor cells in vitro through inhibition of the NF-κB cell signaling pathway.
    Reuter S; Prasad S; Phromnoi K; Kannappan R; Yadav VR; Aggarwal BB
    Mol Cancer Res; 2010 Oct; 8(10):1425-36. PubMed ID: 20826545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kappaB activity.
    Yip KH; Zheng MH; Feng HT; Steer JH; Joyce DA; Xu J
    J Bone Miner Res; 2004 Nov; 19(11):1905-16. PubMed ID: 15476591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel non-peptide small molecules preventing IKKβ/NEMO association inhibit NF-κB activation in LPS-stimulated J774 macrophages.
    De Falco F; Di Giovanni C; Cerchia C; De Stefano D; Capuozzo A; Irace C; Iuvone T; Santamaria R; Carnuccio R; Lavecchia A
    Biochem Pharmacol; 2016 Mar; 104():83-94. PubMed ID: 26776306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.